Future Pipeline

Future applications of telomere profile testing hold immense potential across various fields of healthcare and medicine. The company is seeking collaborations in the following areas to drive development:

​

1. Early Detection of Hematological Cancers:

Utilizing leukocyte telomere profiling to identify early signs of hematological cancers, enabling faster diagnosis and improved treatment outcomes.

​

2. Immune System Monitoring and Infectious Disease Risk:

Telomere length is a critical marker of immune function. Profiling leukocyte telomeres can provide insights into immune health, helping predict susceptibility to infections and guiding targeted vaccination or treatment strategies.

​

3. Risk Assessment for Aging-Related Diseases:

Telomere profile testing can be used to assess an individual’s risk of developing age-related diseases such as cardiovascular disease, Alzheimer’s, and diabetes, facilitating early intervention.

​

4. Monitoring Treatment Efficacy in Telomere-Targeting Therapies:

As telomere-targeting therapies emerge, telomere profiling can serve as a biomarker to monitor the effectiveness of treatments, ensuring optimal therapeutic outcomes and better patient management.

​​

5. Regenerative Medicine and Stem Cell Therapies:

Telomere profiling will play a critical role in monitoring the health and function of stem cells used in regenerative medicine, ensuring the long-term success of stem cell-based therapies.​

effectiveness of treatments, ensuring optimal therapeutic outcomes and better patient management.

​​​

6. Aging and Longevity Research:

Telomere testing will be a cornerstone in aging research, allowing scientists to understand the mechanisms of aging and develop strategies to extend healthy lifespan by targeting telomere maintenance.

Through these collaborations, the company aims to harness the power of telomere profiling to advance healthcare and medicine, addressing both current and future challenges in personalized health management and disease prevention.